SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Article citations

More>>

Yeh, J.J., Routh, E.D., Rubinas, T., Peacock, J., Martin, T.D., Shen, X.J., et al. (2009) KRAS/BRAF Mutation Status and ERK1/2 Activation as Biomarkers for MEK1/2 Inhibitor Therapy in Colorectal Cancer. Molecular Cancer Therapeutics, 8, 834-843. http://dx.doi.org/10.1158/1535-7163.MCT-08-0972

has been cited by the following article: